Drugs / 18F-LY3546117
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT04721756 | Apr 2022 → Apr 2024 | cancer | Avid Radiopharmaceuticals | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 18F-LY3546117 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04721756 ↗ |
| Modality | Diagnostic / imaging agent | “imaging Granzyme B activity in tumors and elsewhere in the body using a Positron Emission Tomography (PET) scan” NCT04721756 ↗ |
| Route | Intravenous | “370 megabecquerel (MBq) intravenous injection” NCT04721756 ↗ |